CFLIPL Interrupts IRF3-CBP-DNA interactions to inhibit IRF3-driven transcription

Journal of Immunology

Volumn 197, Issue 3, 2016, Pages 923-933

  Gates, Lauren T ^a   Shisler, Joanna L ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CASPASE 8; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; DNA; ENHANCEOSOME; FLICE INHIBITORY PROTEIN; FLICE INHIBITORY PROTEIN LONG ISOFORM; INTERFERON; INTERFERON REGULATORY FACTOR 3; PEPTIDES AND PROTEINS; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN TBK1; UNCLASSIFIED DRUG; BONE SIALOPROTEIN (35-62), HUMAN; IRF3 PROTEIN, HUMAN; PEPTIDE FRAGMENT; SIALOGLYCOPROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOREGULATION; LENTIVIRUS INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TRANSCRIPTION INITIATION; BIOSYNTHESIS; CELL LINE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; IMMUNOBLOTTING; IMMUNOPRECIPITATION; METABOLISM; PHYSIOLOGY; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CELL LINE; DNA; GENE EXPRESSION REGULATION; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INTERFERON REGULATORY FACTOR-3; INTERFERON TYPE I; PEPTIDE FRAGMENTS; POLYMERASE CHAIN REACTION; SIALOGLYCOPROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84979506275     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1502611     Document Type: Article

References (61)

1. Hoffmann, H. H., W. M. Schneider, and C. M. Rice. 2015. Interferons and viruses: an evolutionary arms race of molecular interactions. Trends Immunol. 36: 124-138.
2. Tamura, T., H. Yanai, D. Savitsky, and T. Taniguchi. 2008. The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 26: 535-584.
3. Rönnblom, L., and M. L. Eloranta. 2013. The interferon signature in autoimmune diseases. Curr. Opin. Rheumatol. 25: 248-253.
4. Kumari, P., S. Narayanan, and H. Kumar. 2015. Herpesviruses: interfering innate immunity by targeting viral sensing and interferon pathways. Rev. Med. Virol. 25: 187-201.
5. Ikushima, H., H. Negishi, and T. Taniguchi. 2013. The IRF family transcription factors at the interface of innate and adaptive immune responses. Cold Spring Harb. Symp. Quant. Biol. 78: 105-116.
6. Weaver, B. K., K. P. Kumar, and N. C. Reich. 1998. Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol. Cell. Biol. 18: 1359-1368.
7. Yoneyama, M., W. Suhara, Y. Fukuhara, M. Fukuda, E. Nishida, and T. Fujita. 1998. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 17: 1087-1095.
8. Panne, D., S. M. McWhirter, T. Maniatis, and S. C. Harrison. 2007. Interferon regulatory factor 3 is regulated by a dual phosphorylation-dependent switch. J. Biol. Chem. 282: 22816-22822.
9. Lin, R., C. Heylbroeck, P. M. Pitha, and J. Hiscott. 1998. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol. Cell. Biol. 18: 2986-2996.
10. Sato, M., N. Tanaka, N. Hata, E. Oda, and T. Taniguchi. 1998. Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFNbeta gene. FEBS Lett. 425: 112-116.
11. Wang, P., W. Zhao, K. Zhao, L. Zhang, and C. Gao. 2015. TRIM26 negatively regulates interferon-b production and antiviral response through polyubiquitination and degradation of nuclear IRF3. PLoS Pathog. 11: e1004726.
12. Long, L., Y. Deng, F. Yao, D. Guan, Y. Feng, H. Jiang, X. Li, P. Hu, X. Lu, H. Wang, et al. 2014. Recruitment of phosphatase PP2A by RACK1 adaptor protein deactivates transcription factor IRF3 and limits type I interferon signaling. Immunity 40: 515-529.
13. Lei, C. Q., Y. Zhang, T. Xia, L. Q. Jiang, B. Zhong, and H. B. Shu. 2013. FoxO1 negatively regulates cellular antiviral response by promoting degradation of IRF3. J. Biol. Chem. 288: 12596-12604.
14. Yu, Y., and G. S. Hayward. 2010. The ubiquitin E3 ligase RAUL negatively regulates type I interferon through ubiquitination of the transcription factors IRF7 and IRF3. Immunity 33: 863-877.
15. Shirley, S., and O. Micheau. 2013. Targeting c-FLIP in cancer. Cancer Lett. 332: 141-150.
16. Yeh, W. C., A. Itie, A. J. Elia, M. Ng, H. B. Shu, A. Wakeham, C. Mirtsos, N. Suzuki, M. Bonnard, D. V. Goeddel, and T. W. Mak. 2000. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 12: 633-642.
17. Huang, Q. Q., H. Perlman, Z. Huang, R. Birkett, L. Kan, H. Agrawal, A. Misharin, S. Gurbuxani, J. D. Crispino, and R. M. Pope. 2010. FLIP: a novel regulator of macrophage differentiation and granulocyte homeostasis. Blood 116: 4968-4977.
18. Chau, H., V. Wong, N. J. Chen, H. L. Huang, W. J. Lin, C. Mirtsos, A. R. Elford, M. Bonnard, A. Wakeham, A. I. You-Ten, et al. 2005. Cellular FLICE-inhibitory protein is required for T cell survival and cycling. J. Exp. Med. 202: 405-413.
19. Budd, R. C., W. C. Yeh, and J. Tschopp. 2006. cFLIP regulation of lymphocyte activation and development. Nat. Rev. Immunol. 6: 196-204.
20. Handa, P., J. C. Tupper, K. C. Jordan, and J. M. Harlan. 2011. FLIP (Flice-like inhibitory protein) suppresses cytoplasmic double-stranded-RNA-induced apoptosis and NF-kB and IRF3-mediated signaling. Cell Commun. Signal. 9: 16.
21. Randall, C. M., S. Biswas, C. V. Selen, and J. L. Shisler. 2014. Inhibition of interferon gene activation by death-effector domain-containing proteins from the molluscum contagiosum virus. Proc. Natl. Acad. Sci. USA 111: E265-E272.
22. Buskiewicz, I. A., A. Koenig, B. Roberts, J. Russell, C. Shi, S. H. Lee, J. U. Jung, S. A. Huber, and R. C. Budd. 2014. c-FLIP-Short reduces type I interferon production and increases viremia with coxsackievirus B3. PLoS One 9: e96156.
23. Safa, A. R. 2013. Roles of c-FLIP in apoptosis, necroptosis, and autophagy. J. Carcinog. Mutagen Suppl. 6: 003.
24. Wu, Y. H., W. C. Kuo, Y. J. Wu, K. T. Yang, S. T. Chen, S. T. Jiang, C. Gordy, Y. W. He, and M. Z. Lai. 2014. Participation of c-FLIP in NLRP3 and AIM2 inflammasome activation. Cell Death Differ. 21: 451-461.
25. Bayly, R., L. Chuen, R. A. Currie, B. D. Hyndman, R. Casselman, G. A. Blobel, and D. P. LeBrun. 2004. E2A-PBX1 interacts directly with the KIX domain of CBP/p300 in the induction of proliferation in primary hematopoietic cells. J. Biol. Chem. 279: 55362-55371.
26. Ueffing, N., E. Keil, C. Freund, R. Kuhne, K. Schulze-Osthoff, and I. Schmitz. 2008. Mutational analyses of c-FLIPR, the only murine short FLIP isoform, reveal requirements for DiSC recruitment. Cell Death Differ. 15: 773-782.
27. Quintavalle, C., M. Incoronato, L. Puca, M. Acunzo, C. Zanca, G. Romano, M. Garofalo, M. Iaboni, C. M. Croce, and G. Condorelli. 2010. c-FLIPL enhances anti-apoptotic Akt functions by modulation of Gsk3b activity. Cell Death Differ. 17: 1908-1916.
28. Antoine, G., F. Scheiflinger, F. Dorner, and F. G. Falkner. 1998. The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses. Virology 244: 365-396.
29. Shisler, J. L., and B. Moss. 2001. Molluscum contagiosum virus inhibitors of apoptosis: the MC159 v-FLIP protein blocks Fas-induced activation of procaspases and degradation of the related MC160 protein. Virology 282: 14-25.
30. Abramoff, M., P. Magalhaes, and S. Ram. 2004. Image processing with ImageJ. Biophotonics International 11: 36-42.
31. Randall, C. M., J. A. Jokela, and J. L. Shisler. 2012. The MC159 protein from the molluscum contagiosum poxvirus inhibits NF-kB activation by interacting with the IkB kinase complex. J. Immunol. 188: 2371-2379.
32. Shisler, J. L., and X. L. Jin. 2004. The vaccinia virus K1L gene product inhibits host NF-kappaB activation by preventing IkappaBalpha degradation. J. Virol. 78: 3553-3560.
33. Zhang, M., Y. Liu, P. Wang, X. Guan, S. He, S. Luo, C. Li, K. Hu, W. Jin, T. Du, et al. 2015. HSV-2 immediate-early protein US1 inhibits IFN-b production by suppressing association of IRF-3 with IFN-b promoter. J. Immunol. 194: 3102-3115.
34. Yu, J. W., and Y. Shi. 2008. FLIP and the death effector domain family. Oncogene 27: 6216-6227.
35. Wolferstätter, M., M. Schweneker, M. Späth, S. Lukassen, M. Klingenberg, K. Brinkmann, U. Wielert, H. Lauterbach, H. Hochrein, P. Chaplin, et al. 2014. Recombinant modified vaccinia virus Ankara generating excess early doublestranded RNA transiently activates protein kinase R and triggers enhanced innate immune responses. J. Virol. 88: 14396-14411.
36. Alexopoulou, L., A. C. Holt, R. Medzhitov, and R. A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413: 732-738.
37. Kato, H., O. Takeuchi, S. Sato, M. Yoneyama, M. Yamamoto, K. Matsui, S. Uematsu, A. Jung, T. Kawai, K. J. Ishii, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441: 101-105.
38. Zhou, Q., A. Lavorgna, M. Bowman, J. Hiscott, and E. W. Harhaj. 2015. Aryl hydrocarbon receptor interacting protein targets IRF7 to suppress antiviral signaling and the induction of type I interferon. J. Biol. Chem. 290: 14729-14739.
39. Grandvaux, N., M. J. Servant, B. tenOever, G. C. Sen, S. Balachandran, G. N. Barber, R. Lin, and J. Hiscott. 2002. Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J. Virol. 76: 5532-5539.
40. Golks, A., D. Brenner, C. Fritsch, P. H. Krammer, and I. N. Lavrik. 2005. c-FLIPR, a new regulator of death receptor-induced apoptosis. J. Biol. Chem. 280: 14507-14513.
41. Irmler, M., M. Thome, M. Hahne, P. Schneider, K. Hofmann, V. Steiner, J. L. Bodmer, M. Schröter, K. Burns, C. Mattmann, et al. 1997. Inhibition of death receptor signals by cellular FLIP. Nature 388: 190-195.
42. Scaffidi, C., I. Schmitz, P. H. Krammer, and M. E. Peter. 1999. The role of c-FLIP in modulation of CD95-induced apoptosis. J. Biol. Chem. 274: 1541-1548.
43. Valmiki, M. G., and J. W. Ramos. 2009. Death effector domain-containing proteins. Cell. Mol. Life Sci. 66: 814-830.
44. Katayama, R., T. Ishioka, S. Takada, R. Takada, N. Fujita, T. Tsuruo, and M. Naito. 2010. Modulation of Wnt signaling by the nuclear localization of cellular FLIP-L. J. Cell Sci. 123: 23-28.
45. Ozturk, S., K. Schleich, and I. N. Lavrik. 2012. Cellular FLICE-like inhibitory proteins (c-FLIPs): fine-tuners of life and death decisions. Exp. Cell Res. 318: 1324-1331.
46. Kumar, K. P., K. M. McBride, B. K. Weaver, C. Dingwall, and N. C. Reich. 2000. Regulated nuclear-cytoplasmic localization of interferon regulatory factor 3, a subunit of double-stranded RNA-activated factor 1. Mol. Cell. Biol. 20: 4159-4168.
47. Zhu, M., T. Fang, S. Li, K. Meng, and D. Guo. 2015. Bipartite nuclear localization signal controls nuclear import and DNA-binding activity of IFN regulatory factor 3. J. Immunol. 195: 289-297.
48. Thornberry, N. A., H. G. Bull, J. R. Calaycay, K. T. Chapman, A. D. Howard, M. J. Kostura, D. K. Miller, S. M. Molineaux, J. R. Weidner, J. Aunins, et al. 1992. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356: 768-774.
49. Rhodes, D. R., J. Yu, K. Shanker, N. Deshpande, R. Varambally, D. Ghosh, T. Barrette, A. Pandey, and A. M. Chinnaiyan. 2004. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6: 1-6.
50. Wang, P., J. Zhang, A. Bellail, W. Jiang, J. Hugh, N. M. Kneteman, and C. Hao. 2007. Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cells. Cell. Signal. 19: 2237-2246.
51. Ricci, M. S., Z. Jin, M. Dews, D. Yu, A. Thomas-Tikhonenko, D. T. Dicker, and W. S. El-Deiry. 2004. Direct repression of FLIP expression by c-myc is a major determinant of TRAIL sensitivity. Mol. Cell. Biol. 24: 8541-8555.
52. Liu, X., P. Yue, A. H. Schonthal, F. R. Khuri, and S. Y. Sun. 2006. Cellular FLICE-inhibitory protein down-regulation contributes to celecoxib-induced apoptosis in human lung cancer cells. Cancer Res. 66: 11115-11119.
53. Smith, G. L., C. T. Benfield, C. Maluquer de Motes, M. Mazzon, S. W. Ember, B. J. Ferguson, and R. P. Sumner. 2013. Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity. J. Gen. Virol. 94: 2367-2392.
54. Ma, Z., S. R. Jacobs, J. A. West, C. Stopford, Z. Zhang, Z. Davis, G. N. Barber, B. A. Glaunsinger, D. P. Dittmer, and B. Damania. 2015. Modulation of the cGAS-STING DNA sensing pathway by gammaherpesviruses. Proc. Natl. Acad. Sci. USA 112: E4306-E4315.
55. Liu, L., M. T. Eby, N. Rathore, S. K. Sinha, A. Kumar, and P. M. Chaudhary. 2002. The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex. J. Biol. Chem. 277: 13745-13751.
56. Gong, J., S. A. Kumar, G. Graham, and A. P. Kumar. 2014. FLIP: molecular switch between apoptosis and necroptosis. Mol. Carcinog. 53: 675-685.
57. Rajput, A., A. Kovalenko, K. Bogdanov, S. H. Yang, T. B. Kang, J. C. Kim, J. Du, and D. Wallach. 2011. RIG-I RNA helicase activation of IRF3 transcription factor is negatively regulated by caspase-8-mediated cleavage of the RIP1 protein. Immunity 34: 340-351.
58. Fricker, N., J. Beaudouin, P. Richter, R. Eils, P. H. Krammer, and I. N. Lavrik. 2010. Model-based dissection of CD95 signaling dynamics reveals both a proand antiapoptotic role of c-FLIPL. J. Cell Biol. 190: 377-389.
59. Chang, D. W., Z. Xing, Y. Pan, A. Algeciras-Schimnich, B. C. Barnhart, S. Yaish-Ohad, M. E. Peter, and X. Yang. 2002. c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. EMBO J. 21: 3704-3714.
60. Santana-de Anda, K., D. Gómez-Martín, A. E. Monsivais-Urenda, M. Salgado-Bustamante, R. González-Amaro, and J. Alcocer-Varela. 2014. Interferon regulatory factor 3 as key element of the interferon signature in plasmacytoid dendritic cells from systemic lupus erythematosus patients: novel genetic associations in the Mexican mestizo population. Clin. Exp. Immunol. 178: 428-437.
61. Papatriantafyllou, M. 2013. Infection: the interferon paradox. Nat. Rev. Immunol. 13: 392.